Anteris Technologies

Yesterday Dr. Amar Krishnaswamy presented the latest MRI data analysis demonstrating restoration of healthy laminar flow with DurAVR® THV and the impact on the left ventricle. Here were some of the key takeaways: ➡ DurAVR® THV’s biomimetic design provides healthy flow patterns, as measured by flow displacement (FD) and flow reversal ratios (FRR). ➡ Aortic function with DurAVR® THV was similar to healthy controls, measured by left ventricle (LV) end-diastolic volume, LV end-systolic volume, and LV mass. ➡ LV mass decreased in patients treated with DurAVR® THV compared to baseline, suggesting an improvement in LV unloading. ➡ In paired analysis, DurAVR® THV restored LV mass to similar to a healthy control. Click here to view the full presentation: https://lnkd.in/g_8TUJyz #TCT2024 #LaminarFlow #TAVI #TAVR DurAVR® INVESTIGATIONAL USE ONLY. NOT AVAILABLE FOR COMMERCIAL SALE. EU: Exclusively for clinical investigations. US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.

Join us at the TCT Innovation & FDA session tomorrow at 11:36 a.m. for an update on how biomimetic design of the DurAVR® THV is impacting flow dynamics and left ventricle mass regression compared to healthy control.  Click here to add to your calendar: https://lnkd.in/gEPW-YmM #TCT2024 #MovingtheConversationForward #TAVR #TAVI #LaminarFlow DurAVR® INVESTIGATIONAL USE ONLY. NOT AVAILABLE FOR COMMERCIAL SALE. EU: Exclusively for clinical investigations. US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.

Going to TCT? Tune in Monday morning at the Innovation & FDA session to get a first look at new DurAVR® THV data, showing the impact of biomimetic design on flow dynamics and left ventricle mass regression compared to healthy control. Click here to add to your calendar ➡ https://lnkd.in/gEPW-YmM #TCT2024 #TAVR #TAVI #MovingtheConversationForward #aorticstenosis DurAVR® INVESTIGATIONAL USE ONLY. NOT AVAILABLE FOR COMMERCIAL SALE. EU: Exclusively for clinical investigations. US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.

Healthy native flow patterns may not have been the design target for commercially available TAVR valves—but the impact of restoring laminar flow could demonstrate incredible upstream and downstream benefits.* In this video, Dr. João Cavalcante discusses what laminar flow is and why it’s important.   #LaminarFlow #TAVR #TAVI #interventionalcardiology #MovingtheConversationForward    *Sources:  Garg P, Markl M, Sathananthan J, Sellers SL, Meduri C, Cavalcante J. Restoration of flow in the aorta: a novel therapeutic target in aortic valve intervention. Nat Rev Cardiol. 2024;21(4):264-273 .  Chirinos JA, Akers SR, Schelbert E, et al. Arterial Properties as Determinants of Left Ventricular Mass and Fibrosis in Severe Aortic Stenosis: Findings From ACRIN PA 4008. J Am Heart Assoc. 2019;8(1):e010271.     DurAVR® INVESTIGATIONAL USE ONLY. NOT AVAILABLE FOR COMMERCIAL SALE. EU: Exclusively for clinical investigations. US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.

We are excited to partner with CRF for an educational webinar around the impact of flow patterns on disease progression and regression in aortic stenosis. We are committed to moving the conversation forward in TAVR and taking a holistic look at valve performance and whole-heart function.   We are eager to hear from you! Please submit your questions in the link and stay tuned for the webinar to be released after TCT! #MovingtheConversationForward #AorticStenosis #TAVR #TAVI

For #WorldHeartDay our teammates across the globe walked around our offices and completed fun and educational tasks along the route, including short exercises and heart-related trivia. Heart disease is the leading cause of death worldwide. At Anteris, we have a clear focus on disrupting heart valve disease and restoring healthy heart function. We support the World Heart Federation’s mission to inspire and encourage healthy lifestyles by educating people about heart disease symptoms and impacts so people can get the care they need. #UseHeart #HeartDisease #HeartValveDisease #HealthyHeart

Aortic stenosis isn’t just a disease of the valve. In this video, Dr. João Cavalcante and Dr. Christopher Meduri discuss the upstream and downstream impacts on the cardiovascular system and implications for aortic stenosis treatment. At Anteris, we are dedicated to moving the conversation forward in TAVR and taking a whole-heart perspective to assess valve performance and define success in TAVR. #aorticstenosis #interventionalcardiology #TAVI #TAVR #MovingtheConversationForward DurAVR® INVESTIGATIONAL USE ONLY. NOT AVAILABLE FOR COMMERCIAL SALE.  EU: Exclusively for clinical investigations. US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use. 

At Anteris, we believe there is more to discover in valve technologies — and these discoveries will lead to transformative cardiac recovery and make a profound impact on patients' lives. If you're driven by the opportunity to work on groundbreaking treatments and thrive in a fast-paced, collaborative environment, we want you on our team! Be part of something extraordinary and help shape the future of healthcare. We are looking to connect with engineers for internships and regular full-time roles. We welcome early-career and experienced candidates with the following backgrounds: mechanical, biomedical, materials, tissue, and systems engineering. View open jobs: https://lnkd.in/gejY5_ha Get in touch: careers@anteristech.com Michigan Technological University University of Minnesota Duluth University of Minnesota College of Science and Engineering #medicaldevices #internships #careerfair #engineeringjobs

Bioprosthetic valves were designed to open and close to replace a stenotic valve – but they weren’t designed to mimic the natural function and blood flow patterns of a healthy native valve. We’ve developed a new class of TAVR called #biomimetic, meaning it is designed to mimic the performance of a natural, healthy aortic valve. The patented* DurAVR® Transcatheter Heart Valve is made from: ➡ A single piece of anti-calcification tissue**, rather than sewing 3 pieces of tissue together ➡ Tissue that is molded to form native-shaped leaflets with long coaptation designed to mimic natural leaflet movements and minimize leaflet pinwheeling and fluttering*** See the data: https://lnkd.in/gvMsnjRM #TAVR #TAVI #aorticstenosis * US Patent Nos. 11,648,107; 11,622,853; 11,877,927; 11,903,827 ** Neethling W, Rea A, Forster G, Bhirangi K. Performance of the ADAPT-Treated CardioCel® Scaffold in Pediatric Patients With Congenital Cardiac Anomalies: Medium to Long-Term Outcomes, Front Pediatr, 2020;8:198    ***Anteris Data on File DurAVR® INVESTIGATIONAL USE ONLY. NOT AVAILABLE FOR COMMERCIAL SALE. EU: Exclusively for clinical investigations. US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.

Anteris Technologies CEO Wayne Paterson Outlines Rationale For Nasdaq Listing And US IPO With JustStocks Video